Welcome to LookChem.com Sign In|Join Free
  • or
5-CHLOROMETHYL-1-ETHYL-1H-IMIDAZOLE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

790654-82-9

Post Buying Request

790654-82-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

790654-82-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 790654-82-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,0,6,5 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 790654-82:
(8*7)+(7*9)+(6*0)+(5*6)+(4*5)+(3*4)+(2*8)+(1*2)=199
199 % 10 = 9
So 790654-82-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H9ClN2/c1-2-9-5-8-4-6(9)3-7/h4-5H,2-3H2,1H3

790654-82-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(chloromethyl)-1-ethylimidazole

1.2 Other means of identification

Product number -
Other names 5-(CHLOROMETHYL)-1-ETHYL-1H-IMIDAZOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:790654-82-9 SDS

790654-82-9Downstream Products

790654-82-9Relevant academic research and scientific papers

2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG

-

Paragraph 00813, (2016/07/05)

The present invention relates to compounds of formula I that function as inhibitors of PARG (Poly ADP-ribose glycohydrolase) enzyme activity wherein R1a, R1b, R1c, R1d, R1e, W, X1, X2, X3, X4, X5, X6, X7, c are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which PARG activity is implicated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 790654-82-9